Patents by Inventor Vivian Oehler

Vivian Oehler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210285933
    Abstract: Described herein are functional cell assays and methods for selecting a personalized anti-cancer treatment regimen that can improve treatment of cancer in a subject, identify resistance of the subject's cancer to one or more anti-cancer agents and/or validate the current drug treatment strategy.
    Type: Application
    Filed: July 3, 2019
    Publication date: September 16, 2021
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: Pamela BECKER, Su-In LEE, Carl BLAU, Vivian OEHLER, Timothy MARTINS, Raymond J. MONNAT, Jr.
  • Patent number: 10344276
    Abstract: Disclosed are methods of predicting responsiveness of a cancer cell to a tyrosine kinase inhibitor, and methods of predicting the risk of progression of a cancer cell to a more aggressive form. Also provided are methods of reducing proliferation or promoting differentiation of a cancer cell having reduced level of Numb or increased level of Msi. Further disclosed are methods of treating a mammalian subject having cancer and methods of assessing an agent for chemotherapeutic potential.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: July 9, 2019
    Assignee: Duke University
    Inventors: Tannishtha Reya, Hyog Y. Kwon, Takahiro Ito, Dong-Wook Kim, Vivian Oehler, Jerald Radich
  • Publication number: 20160002629
    Abstract: Disclosed are methods of predicting responsiveness of a cancer cell to a tyrosine kinase inhibitor, and methods of predicting the risk of progression of a cancer cell to a more aggressive form. Also provided are methods of reducing proliferation or promoting differentiation of a cancer cell having reduced level of Numb or increased level of Msi. Further disclosed are methods of treating a mammalian subject having cancer and methods of assessing an agent for chemotherapeutic potential.
    Type: Application
    Filed: July 1, 2015
    Publication date: January 7, 2016
    Inventors: Tannishtha Reya, Hyog Y. Kwon, Takahiro Ito, Dong-Wook Kim, Vivian Oehler, Jerald Radich
  • Patent number: 9173963
    Abstract: Disclosed are methods of predicting responsiveness of a cancer cell to a tyrosine kinase inhibitor, and methods of predicting the risk of progression of a cancer cell to a more aggressive form. Also provided are methods of reducing proliferation or promoting differentiation of a cancer cell having reduced level of Numb or increased level of Msi. Further disclosed are methods of treating a mammalian subject having cancer and methods of assessing an agent for chemotherapeutic potential.
    Type: Grant
    Filed: May 14, 2010
    Date of Patent: November 3, 2015
    Assignee: Duke University
    Inventors: Tannishtha Reya, Hyog Y. Kwon, Takahiro Ito, Dong-Wook Kim, Vivian Oehler, Jerald Radich
  • Publication number: 20120208188
    Abstract: Disclosed are methods of predicting responsiveness of a cancer cell to a tyrosine kinase inhibitor, and methods of predicting the risk of progression of a cancer cell to a more aggressive form. Also provided are methods of reducing proliferation or promoting differentiation of a cancer cell having reduced level of Numb or increased level of Msi. Further disclosed are methods of treating a mammalian subject having cancer and methods of assessing an agent for chemotherapeutic potential.
    Type: Application
    Filed: May 14, 2010
    Publication date: August 16, 2012
    Inventors: Tannishtha Reya, Hyog Y. Kwon, Takahiro Ito, Dong-Wook Kim, Vivian Oehler, Jerald Radich